Vanguard Group Inc. Lowers Stock Holdings in Envista Holdings Corporation $NVST

Vanguard Group Inc. lowered its holdings in Envista Holdings Corporation (NYSE:NVST) by 1.2% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 17,074,365 shares of the company’s stock after selling 201,000 shares during the period. Vanguard Group Inc. owned 10.07% of Envista worth $294,704,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. UMB Bank n.a. increased its holdings in shares of Envista by 214.4% during the 1st quarter. UMB Bank n.a. now owns 2,094 shares of the company’s stock worth $36,000 after buying an additional 1,428 shares during the last quarter. Palouse Capital Management Inc. increased its holdings in shares of Envista by 14.4% during the 1st quarter. Palouse Capital Management Inc. now owns 9,444 shares of the company’s stock worth $163,000 after buying an additional 1,186 shares during the last quarter. FourThought Financial Partners LLC acquired a new stake in shares of Envista during the 1st quarter worth $180,000. Vestcor Inc acquired a new stake in shares of Envista during the 1st quarter worth $211,000. Finally, Tower Research Capital LLC TRC increased its holdings in shares of Envista by 51.3% during the 4th quarter. Tower Research Capital LLC TRC now owns 11,057 shares of the company’s stock worth $213,000 after buying an additional 3,751 shares during the last quarter.

Envista Stock Performance

NYSE:NVST opened at $20.66 on Monday. The company has a debt-to-equity ratio of 0.46, a current ratio of 2.44 and a quick ratio of 2.08. The firm has a 50-day moving average of $19.85 and a two-hundred day moving average of $18.57. The stock has a market cap of $3.43 billion, a P/E ratio of 64.56, a PEG ratio of 1.11 and a beta of 1.00. Envista Holdings Corporation has a 1-year low of $14.22 and a 1-year high of $23.00.

Envista (NYSE:NVST) last posted its quarterly earnings data on Thursday, July 31st. The company reported $0.26 earnings per share for the quarter, beating analysts’ consensus estimates of $0.24 by $0.02. The company had revenue of $682.10 million during the quarter, compared to analysts’ expectations of $638.21 million. Envista had a net margin of 2.11% and a return on equity of 4.84%. The firm’s revenue for the quarter was up 7.7% on a year-over-year basis. During the same period in the prior year, the company posted $0.11 EPS. On average, research analysts expect that Envista Holdings Corporation will post 1 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of research firms have recently commented on NVST. Evercore ISI upped their price objective on Envista from $19.00 to $23.00 and gave the stock an “outperform” rating in a report on Wednesday, July 9th. Stifel Nicolaus upped their price objective on Envista from $24.00 to $25.00 and gave the stock a “buy” rating in a report on Friday, August 1st. Robert W. Baird upgraded Envista from a “neutral” rating to an “outperform” rating and upped their price objective for the stock from $21.00 to $23.00 in a report on Tuesday, May 27th. Morgan Stanley upped their price objective on Envista from $16.00 to $17.00 and gave the stock an “equal weight” rating in a report on Friday, August 1st. Finally, UBS Group increased their price target on Envista from $18.00 to $22.00 and gave the company a “neutral” rating in a report on Tuesday, July 29th. One analyst has rated the stock with a sell rating, nine have issued a hold rating, four have given a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $20.92.

Envista Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.